|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 137,900.00 KRW | +9.10% |
|
+6.00% | +30.46% |
| 05-27 | HEALTH ROUNDS-Veracyte genomic test identifies breast cancer patients who can skip chemo | RE |
| 05-15 | ORION Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 5,451B 3.53B 3.09B 2.86B 2.67B 5.02B 334B 5.14B 34.37B 13.27B 165B 13.27B 12.98B 572B | P/E 2026 * |
11.3x | P/E 2027 * | 10.4x |
|---|---|---|---|---|---|
| Enterprise Value | 3.99B 2.58M 2.26M 2.09M 1.95M 3.67M 244M 3.76M 25.14M 9.71M 121M 9.71M 9.49M 419M | EV / Sales 2026 * |
1.08x | EV / Sales 2027 * | 0.94x |
| Free-Float |
56.16% | Yield 2026 * |
2.87% | Yield 2027 * | 3.03% |
| 1 day | +9.10% | ||
| 1 week | +6.00% | ||
| Current month | +6.40% | ||
| 1 month | +6.40% | ||
| 3 months | +2.53% | ||
| 6 months | +30.83% | ||
| Current year | +30.46% |
| 1 week | 120,300 |  | 138,100 |
| 1 month | 120,300 | | 139,700 |
| Current year | 102,000 | | 150,100 |
| 1 year | 99,000 | | 150,100 |
| 3 years | 81,800 | | 150,100 |
| 5 years | 80,200 | | 150,100 |
| 10 years | 75,700 | | 164,500 |
| Manager | Title | Age | Since |
|---|---|---|---|
Seung-Joon Lee
CEO | Chief Executive Officer | 66 | 31/12/2021 |
Cheol-Gon Tam
PRN | Corporate Officer/Principal | 71 | 01/04/1980 |
| Director | Title | Age | Since |
|---|---|---|---|
In-Cheol Heo
BRD | Director/Board Member | 66 | 30/06/2014 |
Wook Lee
BRD | Director/Board Member | 67 | 29/02/2020 |
Seung-Joon Lee
CHM | Chairman | 66 | 31/12/1993 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/01/25 | Others | 17 | 0.0000% | |||
| 19/05/24 | Free | 5,758,550 | 14.5653% | |||
| 19/05/24 | Others | 2,065 | 0.0052% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.10% | +6.00% | +29.36% | +14.73% | 3.53B | |
| -1.19% | +4.04% | +5.87% | -22.43% | 268B | |
| -1.05% | +1.08% | -11.26% | -16.78% | 77.21B | |
| -0.36% | +6.15% | +3.49% | +27.86% | 52.67B | |
| +0.35% | -1.23% | +137.00% | +487.45% | 40.97B | |
| +0.10% | +0.76% | +47.88% | +3.02% | 37.05B | |
| +1.38% | +6.26% | +8.74% | -26.98% | 36.83B | |
| +0.98% | +3.91% | +50.24% | +105.21% | 34.33B | |
| +1.45% | +1.07% | +14.15% | +22.99% | 28.29B | |
| +2.07% | +9.80% | -5.54% | -30.93% | 28.68B | |
| Average | +1.05% | +3.37% | +27.99% | +56.41% | 60.78B | |
| Weighted average by Cap. | -0.40% | +4.24% | +17.55% | +27.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3,701B 2.4B 2.1B 1.94B 1.81B 3.41B 227B 3.49B 23.34B 9.01B 112B 9.01B 8.81B 389B | 3,918B 2.54B 2.22B 2.05B 1.92B 3.61B 240B 3.69B 24.71B 9.54B 118B 9.54B 9.33B 411B |
| Net income | 480B 311M 272M 251M 235M 442M 29.41B 452M 3.03B 1.17B 14.51B 1.17B 1.14B 50.37B | 523B 339M 297M 274M 256M 482M 32.07B 493M 3.3B 1.27B 15.82B 1.27B 1.25B 54.93B |
| Net Debt | -1,464B -949M -831M -767M -716M -1.35B -89.71B -1.38B -9.23B -3.56B -44.26B -3.56B -3.49B -154B | -1,757B -1.14B -997M -920M -859M -1.62B -108B -1.65B -11.08B -4.28B -53.11B -4.28B -4.18B -184B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/06/26 | ₩137,900.00 | +9.10% | 182,220 |
| 26/06/26 | ₩126,400.00 | +1.28% | 179,824 |
| 25/06/26 | ₩124,800.00 | -0.48% | 149,856 |
| 24/06/26 | ₩125,400.00 | -0.08% | 112,839 |
| 23/06/26 | ₩125,500.00 | -3.54% | 140,505 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- A271560 Stock
Select your edition
All financial news and data tailored to specific country editions
